Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Basso

Showing results (241-250 of 379) with videos related to

Pageof 38
Sort By:
European Journal of Medicinal Chemistry|October 27, 2011
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agentRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez Cara, et al.
Journal of Psychosocial Oncology|September 10, 2020
A mixed-methods study of the disease experience in hematopoietic stem cell transplantation survivors: the contribution of text analysisFrancesco Sinatora, Nicoletta Di Florio, Annalisa Traverso, et al.
Journal of Medicinal Chemistry|December 6, 2011
Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activityRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Blood|February 26, 2004
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemiaMarco Tartaglia, Simone Martinelli, Giovanni Cazzaniga, et al.
Advances in Biological Regulation|March 27, 2018
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cellsJessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemiaAndrea Pession, Maria Grazia Valsecchi, Giuseppe Masera, et al.
Haematologica|March 25, 2014
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cellsGiovanni F Torelli, Nadia Peragine, Sara Raponi, et al.
Haematologica|September 13, 2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 studyMaurizio Aricò, Valentino Conter, Maria Grazia Valsecchi, et al.
Immunity|July 8, 2010
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factorIlaria Marigo, Erika Bosio, Samantha Solito, et al.
Leukemia|February 24, 2018
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AMLMatteo Zampini, Claudia Tregnago, Valeria Bisio, et al.
Pageof 38

Showing results (241-250 of 379) with videos related to

Sort By:
Pageof 38
European Journal of Medicinal Chemistry|October 27, 2011
One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazole: a unique, highly active antimicrotubule agentRomeo Romagnoli, Pier Giovanni Baraldi, Carlota Lopez Cara, et al.
Journal of Psychosocial Oncology|September 10, 2020
A mixed-methods study of the disease experience in hematopoietic stem cell transplantation survivors: the contribution of text analysisFrancesco Sinatora, Nicoletta Di Florio, Annalisa Traverso, et al.
Journal of Medicinal Chemistry|December 6, 2011
Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activityRomeo Romagnoli, Pier Giovanni Baraldi, Maria Kimatrai Salvador, et al.
Blood|February 26, 2004
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemiaMarco Tartaglia, Simone Martinelli, Giovanni Cazzaniga, et al.
Advances in Biological Regulation|March 27, 2018
Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cellsJessika Bertacchini, Chiara Frasson, Francesca Chiarini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemiaAndrea Pession, Maria Grazia Valsecchi, Giuseppe Masera, et al.
Haematologica|March 25, 2014
Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cellsGiovanni F Torelli, Nadia Peragine, Sara Raponi, et al.
Haematologica|September 13, 2005
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 studyMaurizio Aricò, Valentino Conter, Maria Grazia Valsecchi, et al.
Immunity|July 8, 2010
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factorIlaria Marigo, Erika Bosio, Samantha Solito, et al.
Leukemia|February 24, 2018
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AMLMatteo Zampini, Claudia Tregnago, Valeria Bisio, et al.
Pageof 38